These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 2659105)

  • 1. Adjuvant therapy in node-negative breast cancer. A panel discussion.
    McGuire WL; Abeloff MD; Fisher B; Glick JH; Henderson IC; Osborne CK
    Breast Cancer Res Treat; 1989 Mar; 13(2):97-115. PubMed ID: 2659105
    [No Abstract]   [Full Text] [Related]  

  • 2. Adjuvant chemotherapy of early breast cancer.
    Med Lett Drugs Ther; 1990 May; 32(818):49-50. PubMed ID: 2333039
    [No Abstract]   [Full Text] [Related]  

  • 3. Systemic adjuvant therapy for node-negative breast cancer: proven or premature?
    Pritchard KI
    Ann Intern Med; 1989 Jul; 111(1):1-4. PubMed ID: 2660644
    [No Abstract]   [Full Text] [Related]  

  • 4. Concerns about adjuvant chemotherapy for breast cancer.
    Mueller CB
    J Med Assoc Ga; 1990 Jun; 79(6):385-7. PubMed ID: 2196327
    [No Abstract]   [Full Text] [Related]  

  • 5. Adjuvant therapy for node-negative breast cancer: a proactive view.
    Glick JH
    Important Adv Oncol; 1990; ():183-97. PubMed ID: 2182518
    [No Abstract]   [Full Text] [Related]  

  • 6. Prognosis and treatment of patients with breast tumors of one centimeter or less and negative axillary lymph nodes.
    Fisher B; Dignam J; Tan-Chiu E; Anderson S; Fisher ER; Wittliff JL; Wolmark N
    J Natl Cancer Inst; 2001 Jan; 93(2):112-20. PubMed ID: 11208880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adjuvant therapy for all patients with breast cancer?
    Lippman ME; Hayes DF
    J Natl Cancer Inst; 2001 Jan; 93(2):80-2. PubMed ID: 11208870
    [No Abstract]   [Full Text] [Related]  

  • 8. Adjuvant therapy with tamoxifen in operable breast cancer. 10 year results of the Naples (GUN) study.
    Bianco AR; De Placido S; Gallo C; Pagliarulo C; Marinelli A; Petrella G; D'Istria M; Delrio G
    Lancet; 1988 Nov; 2(8620):1095-9. PubMed ID: 2903322
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for lymph node-negative, estrogen receptor-negative breast cancer: a tale of three trials.
    Albain KS
    J Natl Cancer Inst; 2004 Dec; 96(24):1801-4. PubMed ID: 15601631
    [No Abstract]   [Full Text] [Related]  

  • 10. Adjuvant therapy for node-negative breast cancer: a cautious interpretation.
    Henderson IC
    Important Adv Oncol; 1990; ():199-216. PubMed ID: 1691137
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic therapy in resectable breast cancer.
    Bonadonna G; Valagussa P
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):727-42. PubMed ID: 2691496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjuvant therapy for breast cancer patients with negative lymph nodes.
    Friedman MA; Dorr FA; Perloff M
    NCI Monogr; 1986; (1):139-44. PubMed ID: 3534587
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of prognostic factors to adjuvant chemotherapy in breast cancer.
    Bonadonna G; Valagussa P
    Recent Results Cancer Res; 1984; 96():34-45. PubMed ID: 6528090
    [No Abstract]   [Full Text] [Related]  

  • 14. [Adjuvant therapy in breast cancer].
    Semiglazov VF
    Vopr Onkol; 2000; 46(1):18-27. PubMed ID: 10789218
    [No Abstract]   [Full Text] [Related]  

  • 15. Tamoxifen and chemotherapy for lymph node-negative, estrogen receptor-positive breast cancer.
    Fisher B; Dignam J; Wolmark N; DeCillis A; Emir B; Wickerham DL; Bryant J; Dimitrov NV; Abramson N; Atkins JN; Shibata H; Deschenes L; Margolese RG
    J Natl Cancer Inst; 1997 Nov; 89(22):1673-82. PubMed ID: 9390536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy for early breast cancer: a time to refine.
    Powles TJ
    J Natl Cancer Inst; 1997 Nov; 89(22):1652-4. PubMed ID: 9390527
    [No Abstract]   [Full Text] [Related]  

  • 17. Adjuvant systemic therapy for resectable breast cancer.
    Bonadonna G; Valagussa P
    J Clin Oncol; 1985 Feb; 3(2):259-75. PubMed ID: 3881562
    [No Abstract]   [Full Text] [Related]  

  • 18. [Adjuvant therapy of breast cancer].
    Semiglazov VF; Abzumanov AS; Bozhok AA; Ivanov VG; Ivanova OA; Barash NIu; Topuzov EE; Seleznev IK; Migmanova NSh; Popova RT; Nurgaziev KSh
    Khirurgiia (Mosk); 2001; (5):52-60. PubMed ID: 11505673
    [No Abstract]   [Full Text] [Related]  

  • 19. Adjuvant CMFP versus CMFP plus tamoxifen versus observation alone in postmenopausal, node-positive breast cancer patients: three-year results of an Eastern Cooperative Oncology Group study.
    Taylor SG; Kalish LA; Olson JE; Cummings F; Bennett JM; Falkson G; Tormey DC; Carbone PP
    J Clin Oncol; 1985 Feb; 3(2):144-54. PubMed ID: 3881561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are current worldwide studies going to answer the important questions remaining in adjuvant chemotherapy of breast cancer?
    Brunner KW
    Recent Results Cancer Res; 1984; 96():224-36. PubMed ID: 6396778
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.